Ensign Peak Advisors’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,296
| Closed | -$217K | – | 1820 |
|
|
2022
Q3 | $217K | Sell |
2,296
-6,805
| -75% | -$643K | ﹤0.01% | 1849 |
|
|
2022
Q2 | $1.77M | Buy |
9,101
+2,558
| +39% | +$498K | ﹤0.01% | 850 |
|
|
2022
Q1 | $1.52M | Buy |
6,543
+5,826
| +813% | +$1.35M | ﹤0.01% | 995 |
|
|
2021
Q4 | $282K | Sell |
717
-2,032
| -74% | -$799K | ﹤0.01% | 1835 |
|
|
2021
Q3 | $1.23M | Buy |
+2,749
| New | +$1.23M | ﹤0.01% | 1345 |
|
|
2021
Q1 | – | Sell |
-1,996
| Closed | -$979K | – | 1829 |
|
|
2020
Q4 | $979K | Hold |
1,996
| – | – | ﹤0.01% | 1411 |
|
|
2020
Q3 | $647K | Buy |
+1,996
| New | +$647K | ﹤0.01% | 1456 |
|